Financials in USD. Standardized financial statements.
A compact view of how Baird Medical Investment Holdings Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue? | $22.54M | $37.04M | $31.46M | $35.09M | $27.72M | $18.12M | $12.21M |
| Revenue Growth? | -39.2% | +17.7% | -10.4% | +26.6% | +53.0% | +48.4% | 0.0% |
| Cost of Revenue? | $3.65M | $4.38M | $4.23M | $7.05M | $4.54M | $2.51M | $1.30M |
| Gross Profit? | $18.88M | $32.65M | $27.23M | $28.04M | $23.18M | $15.61M | $10.91M |
| Gross Margin? | +83.8% | +88.2% | +86.6% | +79.9% | +83.6% | +86.1% | +89.4% |
| Operating Expenses? | $44.42M | $17.34M | $15.37M | $13.03M | $9.76M | $5.75M | $5.30M |
| Operating Income? | -$25.54M | $15.32M | $11.86M | $13.63M | $11.92M | $9.86M | $5.61M |
| EBITDA? | -$24.53M | $16.17M | $12.88M | $16.29M | $14.16M | $10.28M | $5.85M |
| Income Before Tax | -$26.37M | $14.09M | $12.36M | $14.52M | $12.61M | $9.58M | -$5.85M |
| Income Tax Expense | $1.17M | $1.49M | $1.70M | $1.75M | $2.42M | $2.43M | $1.28M |
| Net Income? | -$27.28M | $12.45M | $10.55M | $12.57M | $11.68M | $7.10M | -$7.18M |
| EPS? | $-0.98 | $0.49 | $0.41 | $0.02 | $-0.02 | $0.99 | $-1.00 |
| Diluted EPS? | $-0.98 | $0.49 | $0.41 | $0.02 | $-0.02 | $0.99 | $-1.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality